Karuna Therapeutics Entered into an Exclusive License Agreement with Goldfinch Bio for TRPC4/5 Product Candidates
Shots: Goldfinch Bio will receive $15M up front & is eligible to receive ~$520...
Orbit Entered into a Multi Target Research Agreement with Endevica Bio to Advance Development of Cachexia Therapies
Shots: Orbit & Endevica Bio collaborated to advance the development of cachexi...
uniQure Entered into a License Agreement with Apic Bio for APB-102 to Treat Amyotrophic Lateral Sclerosis in Patients with SOD1 Mu...
Shots: Apic Bio to receive $10M up front & is also eligible to receive ~$45M i...
Ibex, AstraZeneca, and Daiichi Sankyo Enter into a Collaboration to Develop Galen Breast HER2 for the Detection of Breast Cancer
Shots: The companies will jointly develop, clinically validate & adopt Galen B...
HK inno.N Entered into an Exclusive License Agreement with mAbxience for Denosumab Biosimilar to Treat Bone Disease
Shots: HK inno.N collaborated with mAbxience for a denosumab biosimilar referencin...
Helsinn Entered into an Exclusive License and Distribution Agreement with Immedica to Commercialize Akynzeo and Aloxi
Shots: The companies collaborated to commercialize two cancer supportive care prod...
